← Leaderboards
Ty A Ridenour
Univ Of North Carolina Chapel Hill
$9,017,454
Attributed
$16,885,861
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.2M · FY2010–25$10M$7.5M$5M$2.5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,885,861 · 8
By mechanism
U24$9,000,783 · 1
R01$5,870,683 · 3
R42$737,905 · 1
K01$535,152 · 1
R21$435,210 · 1
P50$306,128 · 1
Top collaborators
- Maureen D Reynolds5 shared
- Daniel S Shaw5 shared
- Aysenil Belger3 shared
- Diana H Fishbein3 shared
- Phillip W Graham1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Diana H Fishbein$15,174,808
- Aysenil Belger$18,594,352
- Sierra Bainter$753,296
- Quefeng Li$1,841,334
- Saira Z Sheikh$5,310,451
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignPsychometricsSamplingSubstance Use DisorderCharacteristicsResponseHigh RiskYouthFundingServicesAdolescenceBasePreventionClinical ResearchDrug Abuse PreventionMedicalParticipantProgramsPrevention StrategyAlcohol Or Other Drugs UseChildInterviewChildhoodClinic
Grant awards (26)
Developmental Pathophysiology of Adverse Patterns of Substance Use in Adolescents with Anxiety$694,468
R01 · FY2025 · DA
Developmental Pathophysiology of Adverse Patterns of Substance Use in Adolescents with Anxiety$704,440
R01 · FY2024 · DA
Developmental Pathophysiology of Adverse Patterns of Substance Use in Adolescents with Anxiety$706,786
R01 · FY2023 · DA
ICT Tools for Rare Diseases$194,678
R21 · FY2020 · TR · contact PI
HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young Adults$9,000,783
U24 · FY2019 · DA · contact PI
ICT Tools for Rare Diseases$240,532
R21 · FY2019 · TR · contact PI
Substance Use Screening and Prevention for Adolescents in Pediatric Primary Care$420,685
R01 · FY2018 · DA · contact PI
Substance Use Screening and Prevention for Adolescents in Pediatric Primary Care$641,895
R01 · FY2017 · DA · contact PI
Substance Use Screening and Prevention for Adolescents in Pediatric Primary Care$618,589
R01 · FY2016 · DA · contact PI
Substance Use Screening and Prevention for Adolescents in Pediatric Primary Care$625,208
R01 · FY2015 · DA · contact PI
Substance Use Screening and Prevention for Adolescents in Pediatric Primary Care$639,952
R01 · FY2014 · DA · contact PI
TRANSLATION MODULE$64,199
P50 · FY2014 · DA · contact PI
ALEXSA Standardization for Clinical Use$420,558
R42 · FY2013 · DA · contact PI
TRANSLATION MODULE$57,994
P50 · FY2013 · DA · contact PI
ALEXSA Standardization for Clinical Use$317,347
R42 · FY2012 · DA · contact PI
TRANSLATION MODULE$60,473
P50 · FY2012 · DA · contact PI
TRANSLATION MODULE$58,671
P50 · FY2011 · DA · contact PI
TRANSLATION MODULE$64,791
P50 · FY2010 · DA · contact PI
Inhalant Abuse and Dependence$277,927
R01 · FY2004 · DA
DRUG USE LIABILITY: INVESTIGATING COMPETING MODELS$102,123
K01 · FY2004 · DA
Inhalant Abuse and Dependence$257,233
R01 · FY2003 · DA
DRUG USE LIABILITY: INVESTIGATING COMPETING MODELS$107,068
K01 · FY2003 · DA
Inhalant Abuse and Dependence$283,500
R01 · FY2002 · DA
DRUG USE LIABILITY: INVESTIGATING COMPETING MODELS$107,906
K01 · FY2002 · DA
DRUG USE LIABILITY: INVESTIGATING COMPETING MODELS$107,992
K01 · FY2001 · DA
DRUG USE LIABILITY: INVESTIGATING COMPETING MODELS$110,063
K01 · FY2000 · DA